Puma Biotechnology, Inc. (PBYI)
6.23
-0.17
(-2.66%)
USD |
NASDAQ |
Mar 05, 16:00
6.23
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Cash from Investing (Quarterly) : -26.98M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| Pfizer Inc. | -6.146B |
| Rigel Pharmaceuticals, Inc. | -25.36M |
| CorMedix, Inc. | -291.32M |
| BioXcel Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 14.42M |
| Cash from Financing (Quarterly) | -11.33M |
| Free Cash Flow | 41.73M |
| Free Cash Flow Per Share (Quarterly) | 0.2806 |
| Free Cash Flow to Equity (Quarterly) | 26.96M |
| Free Cash Flow to Firm (Quarterly) | 15.33M |
| Free Cash Flow Yield | 13.23% |